APA (7th ed.) Citation

Eickhardt‐Dalbøge, C. S., Nielsen, H. V., Fuursted, K., Stensvold, C. R., Andersen, L. O. B., Lilje, B., . . . Ingham, A. C. (2024). JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms. European Journal of Haematology, 112(5), 776. https://doi.org/10.1111/ejh.14169

Chicago Style (17th ed.) Citation

Eickhardt‐Dalbøge, Christina Schjellerup, et al. "JAK2V617F Drives Gut Microbiota Differences in Patients with Myeloproliferative Neoplasms." European Journal of Haematology 112, no. 5 (2024): 776. https://doi.org/10.1111/ejh.14169.

MLA (9th ed.) Citation

Eickhardt‐Dalbøge, Christina Schjellerup, et al. "JAK2V617F Drives Gut Microbiota Differences in Patients with Myeloproliferative Neoplasms." European Journal of Haematology, vol. 112, no. 5, 2024, p. 776, https://doi.org/10.1111/ejh.14169.